FDA Gives Full Approval to Alzheimer’s Drug Leqembi

THURSDAY, July 6, 2023 -- The U.S. Food and Drug Administration on Thursday gave full approval to the Alzheimer's drug Leqembi, clearing the way for insurance coverage of the pricey drug.

“The full FDA approval will open the floodgates for...